Search Results - "Klugman, Keith"

Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effects by Klugman, Keith P., Black, Steven

“…Vaccines impact antibiotic-resistant infections in two ways: through a direct reduction in the organisms and strains carrying resistant genes that are…”
Get full text

COVID-19 pneumonia and the appropriate use of antibiotics by Ginsburg, Amy Sarah, Klugman, Keith P

Get full text

Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies by Srikantiah, Padmini, Vora, Prachi, Klugman, Keith P

“…Abstract The Bill & Melinda Gates Foundation supported respiratory syncytial virus (RSV) mortality surveillance studies in several low- and middle-income…”
Get full text

Access to effective antimicrobials: a worldwide challenge by Laxminarayan, Ramanan, Prof, Matsoso, Precious, LLM, Pant, Suraj, BA, Brower, Charles, BA, Røttingen, John-Arne, Prof, Klugman, Keith, MD, Davies, Sally, Prof

“…Summary Recent years have seen substantial improvements in life expectancy and access to antimicrobials, especially in low-income and lower-middle-income…”
Get full text

Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data by Weinberger, Daniel M, Klugman, Keith P, Steiner, Claudia A, Simonsen, Lone, Viboud, Cécile

“…The importance of bacterial infections following respiratory syncytial virus (RSV) remains unclear. We evaluated whether variations in RSV epidemic timing and…”
Get full text

Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape by Mazur, Natalie I, Terstappen, Jonne, Baral, Ranju, Bardají, Azucena, Beutels, Philippe, Buchholz, Ursula J, Cohen, Cheryl, Crowe, James E, Cutland, Clare L, Eckert, Linda, Feikin, Daniel, Fitzpatrick, Tiffany, Fong, Youyi, Graham, Barney S, Heikkinen, Terho, Higgins, Deborah, Hirve, Siddhivinayak, Klugman, Keith P, Kragten-Tabatabaie, Leyla, Lemey, Philippe, Libster, Romina, Löwensteyn, Yvette, Mejias, Asuncion, Munoz, Flor M, Munywoki, Patrick K, Mwananyanda, Lawrence, Nair, Harish, Nunes, Marta C, Ramilo, Octavio, Richmond, Peter, Ruckwardt, Tracy J, Sande, Charles, Srikantiah, Padmini, Thacker, Naveen, Waldstein, Kody A, Weinberger, Dan, Wildenbeest, Joanne, Wiseman, Dexter, Zar, Heather J, Zambon, Maria, Bont, Louis

“…Respiratory syncytial virus is the second most common cause of infant mortality and a major cause of morbidity and mortality in older adults (aged >60 years)…”
Get full text

Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis by Kwatra, Gaurav, MSc, Cunnington, Marianne C, PhD, Merrall, Elizabeth, PhD, Adrian, Peter V, PhD, Ip, Margaret, Prof, Klugman, Keith P, Prof, Tam, Wing Hung, Prof, Madhi, Shabir A, Prof

“…Summary Background The most important risk factor for early-onset (babies younger than 7 days) invasive group B streptococcal disease is rectovaginal…”
Get full text

Pneumococcal Capsules and Their Types: Past, Present, and Future by Geno, K Aaron, Gilbert, Gwendolyn L, Song, Joon Young, Skovsted, Ian C, Klugman, Keith P, Jones, Christopher, Konradsen, Helle B, Nahm, Moon H

“…Streptococcus pneumoniae (the pneumococcus) is an important human pathogen. Its virulence is largely due to its polysaccharide capsule, which shields it from…”
Get full text

Serotype-specific Cardiac Involvement in Pneumococcal Pneumonia by Klugman, Keith P, Feldman, Charles

Get full text

New respiratory syncytial virus immunization products in low- and middle-income countries: potential for cost-effective impact on a high burden of disease in young infants by Srikantiah, Padmini, Klugman, Keith P

“…As new, efficacious respiratory syncytial virus (RSV) immunization products reach the market, affordable pricing as well as improved estimation of disease…”
Get full text

Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study by Omer, Saad B, Goodman, David, Steinhoff, Mark C, Rochat, Roger, Klugman, Keith P, Stoll, Barbara J, Ramakrishnan, Usha

“…Infections during pregnancy have the potential to adversely impact birth outcomes. We evaluated the association between receipt of inactivated influenza…”
Get full text

Usefulness of the Serial Measurement of Vi Antibodies by Klugman, Keith P

“…In a secondary analysis of a published immunogenicity trial comparing Vi capsular polysaccharide vaccine with a similar dose (25 µg) conjugated to tetanus…”
Get full text

Impact of conjugate pneumococcal vaccines on antibiotic resistance by Dagan, Ron, Prof, Klugman, Keith P, Prof

“…Summary Reduction of drug-resistant Streptococcus pneumoniae (DRSP) by pneumococcal conjugate vaccines (PCVs) has recently become a reality. We now know that…”
Get full text

Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis by Simonsen, Lone, Prof, Taylor, Robert J, PhD, Schuck-Paim, Cynthia, PhD, Lustig, Roger, BA, Haber, Michael, Prof, Klugman, Keith P, Prof

“…Summary Background In March 2010, 13-valent pneumococcal conjugate vaccine (PCV13) replaced the seven-valent vaccine in the USA. We assessed the effect of…”
Get full text

Global epidemiology of invasive meningococcal disease by Jafri, Rabab Z, Ali, Asad, Messonnier, Nancy E, Tevi-Benissan, Carol, Durrheim, David, Eskola, Juhani, Fermon, Florence, Klugman, Keith P, Ramsay, Mary, Sow, Samba, Zhujun, Shao, Bhutta, Zulfiqar A, Abramson, Jon

“…Neisseria meningitidis is one of the leading causes of bacterial meningitis globally and can also cause sepsis, pneumonia, and other manifestations. In…”
Get full text

Time for a third-generation pneumococcal conjugate vaccine by Klugman, Keith P, Rodgers, Gail L

Get full text

Triumph of Pneumococcal Conjugate Vaccines: Overcoming a Common Foe by Rodgers, Gail L, Whitney, Cynthia G, Klugman, Keith P

“…Abstract Pneumococcal conjugate vaccine (PCV) has reduced the burden of pneumococcal disease by the near elimination of vaccine serotypes from countries giving…”
Get full text

Antibiotic prophylaxis-Preventing severe infections and saving lives in poor countries with very high mortality risk by Klugman, Keith P, Izadnegahdar, Rasa

“…In a Perspective, Keith P. Klugman and Rasa Izadnegahdar from the Bill and Melinda Gates Foundation discuss the potentials and risks of antibiotic prophylaxis…”
Get full text

Antibiotics for paediatric community-acquired pneumonia in resource-constrained settings by Ginsburg, Amy Sarah, Klugman, Keith P

“…Despite Streptococcus pneumoniae and Haemophilus influenzae type b vaccination strategies, pneumonia remains the leading infectious cause of child mortality…”
Get full text

Effects of Vaccination on Invasive Pneumococcal Disease in South Africa by von Gottberg, Anne, de Gouveia, Linda, Tempia, Stefano, Quan, Vanessa, Meiring, Susan, von Mollendorf, Claire, Madhi, Shabir A, Zell, Elizabeth R, Verani, Jennifer R, O’Brien, Katherine L, Whitney, Cynthia G, Klugman, Keith P, Cohen, Cheryl

“…Invasive pneumococcal disease is an important cause of severe illness. In South Africa, a national program to vaccinate children with the conjugated…”
Get full text